No Data Yet
The global microplastic analysis market is forecast to grow from $266.9 million in 2025 to $383.1 million by 2030, a 7.5% CAGR, driven by increasing regulatory pressure and health risk awareness.
Agilent Technologies will present its strategic outlook at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, building on its previously stated goal of 5-7% annual core revenue growth.
Agilent Technologies maintains a net debt of $1.57 billion, with its EBIT covering interest expenses 29.6 times over, indicating a conservative debt strategy despite a recent 4.2% drop in EBIT.